Records containing: Hepatotoxicity
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-10-06A Long-term Study to Further Evaluate the Risk of Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
-
CLINICAL_TRIALS study record update · 2024-08-21Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia
-
CLINICAL_TRIALS study record update · 2024-04-05Proof-of-concept Phase II Study to Evaluate the Efficacy and Safety of Prednisone in the Treatment of Idiosyncratic Hepatotoxicity and Its Mechanistic Pathways Through an Integrative Analysis: the DILI-CORT Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-04-03ClinicalTrials.gov study NCT00137059
-
CLINICAL_TRIALS study record update · 2023-04-05Monitoring the HePAtological TOXicity of Drugs
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-05-08Effect of Race/Ethnicity and Genes on Acetaminophen Pharmacokinetics
-
CLINICAL_TRIALS study record update · 2018-07-26Paracetamol Hepatotoxicity After Therapeutic Doses: Susceptibility Factors and Early Detection Biomarkers
-
CLINICAL_TRIALS study record update · 2014-03-17The Application of the N-acetyltransferase 2 (NAT2) Genotyping in Re-challenge Protocol of Isoniazid (INH) Titration in Patients With Anti-TB Medications-induced Hepatitis
-
CLINICAL_TRIALS study record update · 2012-12-27The Application of the N-acetyltransferase 2 (NAT2) Genotyping in Re-challenge Protocol of Isoniazid (INH) Titration in Patients With Anti-TB Medications-induced Hepatitis